Clinical and epidemiological characteristics of patients with asymptomatic clinical course of COVID-19 in Santiago de Cuba province
Keywords:
COVID-19, coronavirus SARS-CoV-2, polymerase chain reaction, asymptomatic diseases.Abstract
Introduction: The COVID-19 is an infectious disease caused by the SARS-CoV-2 virus, which is presented in an asymptomatic way in up to 80 % of the cases at world level.
Objective: To characterize the patients with asymptomatic clinical course of the COVID-19.
Methods: An observational, descriptive and cross-sectional study was carried out in Santiago de Cuba province, with retrospective gathering of the information, from March to May, 2020, belonging to 13 patients with diagnosis of the disease and no symptomatic manifestation of it.
Results: Of the patients with positive results for coronavirus in the province, 26,0 % were asymptomatic; there was a predominance of the 20-39 years-old (38,4 %), and the 60 and more years (30,7 %) in these age groups, as well as of the female sex (84,6 %). Equally, 30,7 % suffered from non-communicable chronic diseases and 38,5 % turned out to be infection source to other people.
Conclusions: The frequency of asymptomatic patients in Santiago de Cuba was different from that notified in the rest of the country and in other nations, which could not be conditioned by the emergence of episodes or buds and the registered low incidence; nevertheless, in the analysis of the variables, there were no discrepancies with the reports on patients with this clinical form of disease.
Downloads
References
2. Lo que se sabe de los asintomáticos con COVID-19. Revista La Vanguardia. 2020 Abr [citado 20/05/2020]. Disponible en: https://www.vanguardia.com/colombia/explicador-lo-que-se-sabe-de-los-asintomaticos-con-el-covid-19-JA2288957
3. Cuba. Ministerio de Salud Pública de la República de Cuba, Centro para el Control Estatal de Medicamentos, Equipos y Dispositivos Médicos. Coronavirus en Cuba. Información Oficial del MINSAP, 12 de agosto de 2020. La Habana: CECMED; 2020 [citado 20/05/2020]. Disponible en: https://www.cecmed.cu/noticias/coronavirus-cuba-12-agosto-2020
4. Ministerio de Salud Pública de la República de Cuba, Centro para el Control Estatal de Medicamentos, Equipos y Dispositivos Médicos. Coronavirus en Cuba. Información Oficial del MINSAP, 22 de mayo de 2020. La Habana: CECMED; 2020 [citado 20/05/2020]. Disponible en: https://www.cecmed.cu/noticias/coronavirus-cuba-22-mayo-2020
5. Medsalud. ¿Cómo evoluciona la infección por el VIH? [citado 20/05/2020]. Disponible en: https://www.msdsalud.es/cuidar-en/vih-sida/vih-sida-aprende/evoluciona-infeccion-vih.html
6. Sitio Oficial de Gobierno del Ministerio de Salud Pública en Cuba. COVID-19. Parte de cierre del 22 de abril 2020 a las 12 de la noche [citado 20/05/2020]. Disponible en: https://salud.msp.gob.cu/2020/04/23/
7. Heneghan C, Brassey J, Jefferson T. COVID 19: What proportion are asymptomatic? Centre for Evidence-Based Medicine. CEBM. 2020 Abr [citado 20/05/2020]. Disponible en: https://www.cebm.net/covid-19/covid-19-what-proportion-are-asymptomatic/
8. Oxford COVID-19 Evidence Service. Transmission Dynamic Centre for Evidence-Based Medicine. CEBM. 2020 Abr [citado 20/05/2020]. Disponible en: https://www.cebm.net/oxford-covid-19-evidence-service/
9. Antoni T. Los casos asintomáticos. LaVanguardia.com 23 de abril de 2020 [citado 20/05/2020]. Disponible en: https://www.lavanguardia.com/vida/20200423/48683512885/los-casos-asintomaticos.html
10. Fuminari M, Ryota M, Hiroshi N. Estimating the Asymptomatic Ratio of Norovirus Infection During Foodborne Outbreaks with Laboratory Testing in Japan. J Epidemiol. 2018 [citado 20/05/2020];28(9):382-7. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6111106/
11. Kenji M, Tetsuro K, Chowell G. Transmission potential of modified measles during an outbreak, Japan, March‒May 2018. Euro Surveill. 2018 [citado 20/05/2020];23(24). Disponible en: https://doi.org/10.2807/1560-7917.EN.2018.23.24.1800239
12. Zhiliang H, Ci S, Chuanjun X, Guangfu J, Yaling C, Xin X, et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Sci China Life Sci. 2020 [citado 20/05/2020];63(5):706-11. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088568/pdf/11427_2020_Article_1661.pdf
13 Coiras M, Serrano S; Grupo de Análisis Científico de Coronavirus del Instituto de Salud Carlos III. Informe del Grupo de Análisis Científico de Coronavirus del ISCIII (GACC-ISCIII). Madrid: Ministerio de Ciencia e Innovación; 2020 [citado 20/05/2020]. Disponible en: https://www.conprueba.es/sites/default/files/noticias/2020-05/MANIFESTACIONES%20CL%C3%8DNICAS%20DE%20LA%20ENFERMEDAD%20COVID-19.pdf
14. Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection: A narrative Review. Ann Intern Med. 2020 Jun [citado 20/05/2020]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281624/pdf/aim-olf-M203012.pdf
15. Sijia T, Nan H, Jing L, Kun C, Xuqin K, Zhenjun X, et al. Characteristics of COVID-19 infection in. Beijing. J Infect. 2020 [citado 20/05/2020];80(4):401-6. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102527/
16. González Moraga FJ. Por qué Covid-19 en algunas personas es asintomático, mientras que en otras es letal. Infosalus.com [actualizado 02/05/2020; citado 23/05/2020]. Disponible en: https://www.infosalus.com/salud-investigacion/noticia-covid-19-algunas-personas-asintomatico-mientras-otras-letal-20200423083543.html
17. La experiencia de España frente al coronavirus, lecciones para otros países. Noticias ONU. 8 Abr 2020 [citado 20/05/2020]. Disponible en https://news.un.org/es/story/2020/04/1472622
18. Mizumoto Kenji, Kagaya Katsushi, Zarebski Alexander, Chowell Gerardo. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. 2020 [citado 20/05/2020];25(10). Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078829/pdf/eurosurv-25-10-1.pdf
19. World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). 16-24 February 2020. Geneva: WHO; 2020 [citado 20/05/2020]. Disponible en: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
20. Aragón-Nogales R, Vargas-Almanza I, Miranda-Novales MG. COVID-19 por SARS-CoV-2: la nueva emergencia mundial. Rev Mex Pediatr 2019 [citado 20/05/2020];86(6);213-8. Disponible en: https://www.medigraphic.com/pdfs/pediat/sp-2019/sp196a.pdf
Published
How to Cite
Issue
Section
License
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.
![Secimed](/templates/images/secimed.png"){kind=small}
Guidelines for authors
